<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>研发客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-27T07:22:07+08:00</updated>
  <subtitle>《研发客》公众号由上海汐潮信息技术有限公司提供，行业资深中英文独立编辑记者创办。我们观察药物创新生态，报道临床研究与监管科学。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>勃林格殷格翰创新大赛：与本土创新携手同行｜第一现场</title>
    <updated>2020-11-26T21:58:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/wunv6izniiNn475qEBCl2Q</id>
    <link href="https://mp.weixin.qq.com/s/wunv6izniiNn475qEBCl2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第二代选择性核输出抑制剂ATG-016(Eltanexor)治疗骨髓增生异常综合征在中国获I/II期临床试验批准｜新闻稿</title>
    <updated>2020-11-26T21:58:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/LnJZVg-JHPgdVyePpAfwRA</id>
    <link href="https://mp.weixin.qq.com/s/LnJZVg-JHPgdVyePpAfwRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康新冠疫苗达到预防COVID-19主要疗效终点 | 第一现场</title>
    <updated>2020-11-25T21:26:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/SCsKzxr5vKkITfWepPy-0Q</id>
    <link href="https://mp.weixin.qq.com/s/SCsKzxr5vKkITfWepPy-0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从上海研发中心落地再看百济神州研发布局｜第一现场</title>
    <updated>2020-11-24T21:16:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/p1l__B4TUuxibH59RTlgqQ</id>
    <link href="https://mp.weixin.qq.com/s/p1l__B4TUuxibH59RTlgqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>唯一肠道选择性生物制剂安吉优®中国上市 | 新闻稿</title>
    <updated>2020-11-24T21:16:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/HjuKC8vdEmnx4XS7RraTnA</id>
    <link href="https://mp.weixin.qq.com/s/HjuKC8vdEmnx4XS7RraTnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>被赛诺菲收购的Kiadis是什么来头？ | 公司分析</title>
    <updated>2020-11-24T21:16:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/vF1t3it7YH1cc0VVMAm7bQ</id>
    <link href="https://mp.weixin.qq.com/s/vF1t3it7YH1cc0VVMAm7bQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>监管指南与临床融合促创新｜第一现场</title>
    <updated>2020-11-22T23:50:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/iRdNJFBbryuQQR0RLZYGyg</id>
    <link href="https://mp.weixin.qq.com/s/iRdNJFBbryuQQR0RLZYGyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《中国药品采购政策研究报告2020》：全景式研究带量采购 | 新闻稿</title>
    <updated>2020-11-22T23:50:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/8prvU5bk2TvAQpaB_TdBsw</id>
    <link href="https://mp.weixin.qq.com/s/8prvU5bk2TvAQpaB_TdBsw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“致远，创新未来”2020张江药谷&amp;BIOPR年会</title>
    <updated>2020-11-22T13:26:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/6-JiaQ-cKoA8KR3QX8VugQ</id>
    <link href="https://mp.weixin.qq.com/s/6-JiaQ-cKoA8KR3QX8VugQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛诺菲巴斯德重组四价流感疫苗欧盟获批  力争尽快引进中国 | 新闻稿</title>
    <updated>2020-11-20T21:06:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/ZbxqG09zM4sG2cnrNY4DlA</id>
    <link href="https://mp.weixin.qq.com/s/ZbxqG09zM4sG2cnrNY4DlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关于“红海”和“蓝海”的思考｜老梁说药</title>
    <updated>2020-11-20T09:33:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/drQoRPisog-jpN8jF3G8CQ</id>
    <link href="https://mp.weixin.qq.com/s/drQoRPisog-jpN8jF3G8CQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛诺菲携优秀初创企业  持续加码数字化医疗领域 | 新闻稿</title>
    <updated>2020-11-20T09:33:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/QHYaaoyb_vWXkiuJl2JHkw</id>
    <link href="https://mp.weixin.qq.com/s/QHYaaoyb_vWXkiuJl2JHkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪医药有限公司于香港联合交易所主板挂牌 | 新闻稿</title>
    <updated>2020-11-20T09:33:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/QaoisseWfcPH6x5PRXhsgA</id>
    <link href="https://mp.weixin.qq.com/s/QaoisseWfcPH6x5PRXhsgA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞中国研发中心15周年：多位专家共议研发新突破与新挑战 | 进博会专题</title>
    <updated>2020-11-17T19:55:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/9u4eo4PV5eVTGJqnrmExiQ</id>
    <link href="https://mp.weixin.qq.com/s/9u4eo4PV5eVTGJqnrmExiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首个皮下注射PD-L1抗体KN035（恩沃利单抗注射液）提交生物制品上市许可申请 | 新闻稿</title>
    <updated>2020-11-17T19:55:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/6Zzfthiv4m7CrTCTlFzT5g</id>
    <link href="https://mp.weixin.qq.com/s/6Zzfthiv4m7CrTCTlFzT5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11月21日客论直播 ∣ 新法规形势下的国际多中心临床避坑指南</title>
    <updated>2020-11-17T19:55:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/QBwTRIkzgDoUU161M3bWjw</id>
    <link href="https://mp.weixin.qq.com/s/QBwTRIkzgDoUU161M3bWjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>水木未来第二届冷冻电镜与药物创新发现论坛 | 会讯</title>
    <updated>2020-11-17T19:55:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/wizCJt3ztT9CHKxupjsaSg</id>
    <link href="https://mp.weixin.qq.com/s/wizCJt3ztT9CHKxupjsaSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>天境生物CD47抗体lemzoparlimab I期数据公布：在实体瘤患者中观察到初步疗效信号 | 第一现场</title>
    <updated>2020-11-16T22:43:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/Th4Lb6qK7TNva3PZM6GbjA</id>
    <link href="https://mp.weixin.qq.com/s/Th4Lb6qK7TNva3PZM6GbjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>1类创新化药贺普拉肽治疗慢性乙肝Ⅱ期临床试验启动 | 新闻稿</title>
    <updated>2020-11-16T22:43:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/EXCWO4XGRJ1H_G5uGlQk2w</id>
    <link href="https://mp.weixin.qq.com/s/EXCWO4XGRJ1H_G5uGlQk2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020中国肿瘤学大会：聚焦新疗法与新理念 | 新闻稿</title>
    <updated>2020-11-16T22:43:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/Dk-n2lKwoLGl_fg6No-kSQ</id>
    <link href="https://mp.weixin.qq.com/s/Dk-n2lKwoLGl_fg6No-kSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>